ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976

Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals

May 25, 1984

AACI Asks NCI for Better Definitions Of Center Types, Development Of Objectives, Priorities

June 25, 1976

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012